News related to Skelaxin (Metaxalone) and/or conditions it is approved for
FDA Clears The DPL (Deep Penetrating Light) Therapy System For Over-the-Counter - Home Use Source: Arthritis / Rheumatology News From Medical News Today [2008.11.18] LED Technologies, LLC announced today that the U.S. Food and Drug Administration (FDA) cleared their DPL™ Therapy System for the relaxation of muscles and relief of muscle spasms, temporary relief of minor muscle and joint aches, pains and stiffness; temporary relief of minor pain and stiffness associated with arthritis; and to temporarily increase local blood circulation.
|